1.38
전일 마감가:
$1.36
열려 있는:
$1.38
하루 거래량:
891.88K
Relative Volume:
0.77
시가총액:
$263.80M
수익:
$156.37M
순이익/손실:
$-37.49M
주가수익비율:
-6.5714
EPS:
-0.21
순현금흐름:
$-47.77M
1주 성능:
-4.83%
1개월 성능:
+2.99%
6개월 성능:
-25.41%
1년 성능:
-37.27%
Cerus Corp Stock (CERS) Company Profile
명칭
Cerus Corp
전화
(925) 288-6000
주소
1220 CONCORD AVENUE, CONCORD, CA
CERS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CERS
Cerus Corp
|
1.38 | 277.18M | 156.37M | -37.49M | -47.77M | -0.21 |
![]()
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-04-12 | 개시 | Craig Hallum | Buy |
2023-01-20 | 다운그레이드 | BTIG Research | Buy → Neutral |
2023-01-17 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
2020-10-08 | 재개 | BTIG Research | Buy |
2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
2020-02-26 | 개시 | BTIG Research | Buy |
2019-11-13 | 업그레이드 | BTIG Research | Neutral → Buy |
2019-08-28 | 개시 | Stifel | Buy |
2019-08-23 | 재개 | Stephens | Overweight |
2018-01-05 | 재개 | Cantor Fitzgerald | Overweight |
2017-12-08 | 재개 | BTIG Research | Neutral |
2016-07-07 | 재개 | Cantor Fitzgerald | Buy |
2015-12-17 | 다운그레이드 | Wedbush | Outperform → Neutral |
2014-05-02 | 재확인 | MLV & Co | Buy |
2013-04-24 | 재확인 | Cantor Fitzgerald | Buy |
2013-03-15 | 재확인 | MLV & Co | Buy |
2012-04-17 | 개시 | Cantor Fitzgerald | Buy |
2012-02-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2011-11-10 | 재확인 | MLV & Co | Buy |
2011-06-03 | 개시 | Wedbush | Outperform |
2011-03-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2010-03-09 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2009-08-26 | 업그레이드 | Avondale | Mkt Perform → Mkt Outperform |
모두보기
Cerus Corp 주식(CERS)의 최신 뉴스
Cerus stock rises after securing additional $7.2 million DoD contract - Investing.com
Cerus receives $7.2 million DoD contract amendment for trauma treatment - Investing.com
Cerus Secures $7.2M DoD Contract to Advance Breakthrough Trauma Treatment Study - Stock Titan
How Cerus Corporation stock performs during market volatilityTrending Stock Alert - Newser
What makes Cerus Corporation stock price move sharplyMomentum Buy Alert - Newser
Why Cerus Corporation stock attracts strong analyst attentionConsistent Growth Alert - Newser
Cerus Q4 2024 slides: Positive EBITDA achieved amid 15% revenue growth - Investing.com Canada
Cerus Q4 2024 slides: Positive EBITDA achieved amid 15% revenue growth By Investing.com - Investing.com South Africa
Cerus Leads The Pack Of 3 Promising Penny Stocks - Yahoo Finance
Cerus advances European regulatory review for INTERCEPT RBC system - Investing.com
Cerus Provides INTERCEPT Red Blood Cell CE Mark Application Update - Investing.com
Cerus Appoints New Chair Following Board Retirement - TipRanks
Daily Market Movement: Cerus Corp (CERS) Sees a 6.82 Increase, Closing at 1.41 - DWinneX
26,884 Shares in Cerus Co. (NASDAQ:CERS) Purchased by Pallas Capital Advisors LLC - Defense World
Cerus Corporation Celebrates World Blood Donor Day 2025 - Yahoo Finance
Cerus at Goldman Sachs Conference: Pathogen Reduction Leadership - Investing.com
Cerus at Goldman Sachs Conference: Pathogen Reduction Leadership By Investing.com - Investing.com Canada
Cerus Corp shareholders approve equity plan amendment By Investing.com - Investing.com South Africa
Cerus Corp shareholders approve equity plan amendment - Investing.com
Sigyn Therapeutics (OTCMKTS:SIGY) & Cerus (NASDAQ:CERS) Head to Head Comparison - Defense World
Two Sigma Investments LP Acquires 326,605 Shares of Cerus Co. (NASDAQ:CERS) - Defense World
Mackenzie Financial Corp Acquires 17,704 Shares of Seanergy Maritime Holdings Corp. (NASDAQ:SHIP) - Defense World
3 Promising Penny Stocks With Market Caps Over $90M - Yahoo Finance
Cerus Management Takes Stage at Goldman Sachs Healthcare Conference: Key Updates Coming June 11 - Stock Titan
Cantor Fitzgerald maintains Cerus stock rating due to regulatory approvals By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains Cerus stock rating due to regulatory approvals - Investing.com
Cerus to present new INTERCEPT Blood System data at ISBT Congress - Investing.com
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan - Yahoo Finance
Cerus (CERS) Gains French and Swiss Regulatory Approvals for New Device | CERS Stock News - GuruFocus
Cerus gains regulatory nods for blood safety device in Europe - Investing.com
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device - Business Wire
Next-Gen Blood Safety Device INT200 Secures Dual European Approvals: 3X Space Efficiency Breakthrough - Stock Titan
Cerus Co. (NASDAQ:CERS) Stake Boosted by Jane Street Group LLC - Defense World
When Should You Buy Cerus Corporation (NASDAQ:CERS)? - Yahoo Finance
Price T Rowe Associates Inc. MD Buys 34,694 Shares of Cerus Co. (NASDAQ:CERS) - Defense World
Stifel Financial Corp Grows Stock Position in Cerus Co. (NASDAQ:CERS) - Defense World
Raymond James Financial Inc. Acquires Shares of 244,073 Cerus Co. (NASDAQ:CERS) - Defense World
Closing Strong: Cerus Corp (CERS) Ends at 1.25, Down -3.85 from Last Close - DWinneX
Cerus Corporation Announces First Quarter 2025 Financial Results - ADVFN
Analysts Offer Insights on Healthcare Companies: Cerus (CERS), Stryker (SYK) and Praxis Precision Medicines (PRAX) - The Globe and Mail
JPMorgan Chase & Co. Grows Stock Holdings in Cerus Co. (NASDAQ:CERS) - Defense World
Cerus Corporation (NASDAQ:CERS) Just Reported, And Analysts Assigned A US$4.25 Price Target - Yahoo Finance
Cerus Corporation (NASDAQ:CERS) Q1 2025 Earnings Call Transcript - Insider Monkey
Cerus Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Cerus: Q1 Earnings Snapshot - MySA
Earnings call transcript: Cerus Q1 2025 revenue up, stock dips post-earnings - Investing.com
CERUS CORP SEC 10-Q Report - TradingView
Cerus Corp Reports Q1 2025 Earnings: EPS Matches Estimate at -$0 - GuruFocus
Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Cerus Corp (CERS) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Cerus Corp (CERS) deserves deeper analysis - uspostnews.com
Cerus Corp (CERS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):